[Asia Economy Reporter Minji Lee] The KOSPI and KOSDAQ indices started higher due to buying momentum from individual investors.


At 9:13 a.m. on the 13th, the KOSPI was at 2164.09, up 0.64% (13.84 points) from the previous session. The index opened at 2170.51, up 0.94% (20.26 points) from the previous close. Currently, individual investors have net bought stocks worth 43.4 billion KRW in the KOSPI market, while foreigners and institutions sold stocks worth 2.8 billion KRW and 52.6 billion KRW, respectively.


Sangyoung Seo, a researcher at Kiwoom Securities, said, "The recent U.S. stock market rose due to expectations of improved earnings following Gilead's clinical data results and the reopening of Disney and cruise operations, boosting financial stocks and Netflix." He added, "Despite the spread of COVID-19 in the U.S., the market is expected to show an upward trend driven by optimism about Gilead."


Among the top market capitalization stocks, Samsung Electronics (1.33%), SK Hynix (0.12%), LG Chem (1.51%), and Samsung SDI (0.13%) rose. On the other hand, Naver (-2.68%), Samsung Biologics (-1.23%), and Celltrion (-0.15%) declined.


At the same time, the KOSDAQ index was trading at 775.14, up 0.30% (2.33 points) from the previous session. The index opened at 777.92, up 0.66% (5.11 points) from the previous close. In the KOSDAQ market, individual investors bought stocks worth 67.6 billion KRW, while foreigners and institutions sold stocks worth 40.7 billion KRW and 23.1 billion KRW, respectively.



Among the top market capitalization stocks in the KOSDAQ market, Seegene (3.01%), Studio Dragon (0.66%), and KMW (3.38%) rose. Celltrion Healthcare (-0.85%), Celltrion Pharm (-0.07%), and HL Biopharma (-1.95%) declined.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing